Food and Drug Administration

Science Board to the Food and Drug Administration

November 6, 2005


CDER Drug Safety Update, Steven Galson, MD, MPH (HTM) (PPT)

CDER Drug Safety Oversight Board, Douglas Throckmorton, MD (HTM) (PPT)

Update on FDA Cross-Cutting Initiatives, Dr. Janet Woodcock (HTM) (PPT)

FDA's New Bioresearch Monitoring Initiaive, Dr. Janet Woodcock (HTM) (PPT)

External Peer Review of the FDA Office of Regulatory Affairs Pesticide Program (HTM) (PPT)

Science Prioritization Process -- How it Works and What are Some Results?, Larry Kessler, ScD (HTM) (PPT)

National Antimicrobial Resistance Monitoring System (NARMS), Linda Youngman, MS, PhD (PPT) (PDF)

Open Public Hearing

The Reduction of Animal Use in medical Product Development, Sadhana Dhruvakumar, People for the Ethical Treatment of Animals (PDF)

Presentation on Behalf of the Union of Concerned Scientists and Kee Antibiotics Working, Susan Prolman, Esq. (PDF)